We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Dr. Heike Kofler, Amy Miller, Jennifer Riter One of the critical success factors for packaging lyophilized drugs is protection against product degradation caused by moisture. Moisture can be introduced into a lyophilized drug product cake from the elastomeric stopper and from the atmospheric headspace; it can also permeate through the stopper, a process known as moisture transmission.
West Pharmaceutical Services, Inc.
To better understand moisture transmission and retention, West performed a three-year study to determine the effects of autoclave and drying times on residual moisture in lyophilization stoppers. Lyophilized lactose was also evaluated to determine the ability of lyophilization stoppers to protect drug product from moisture absorption.
Lyophilization stoppers have been designed to permit proper lyophilization of drug product in a lyophilization chamber. Prior to packaging the drug product, many of these stoppers are washed and steam sterilized, which may increase moisture content within the stopper, and then dried to drive out the moisture in the stopper. If the drying conditions for the stopper are not optimized, residual moisture can transfer into the lyophilized drug product over time. Lyophilized drug product is often unstable in its aqueous form. Therefore, moisture from the lyophilization stopper may have a detrimental effect on the drug product. This study, conducted by West Analytical Services, was performed to determine the moisture content of lyophilization stoppers exposed to a typical autoclave sterilization cycle and dried for 1, 4, and 8 hours. The lyophilization stoppers were exposed to typical lyophilization parameters to determine if the stopper transfers moisture. The stoppers evaluated were made from two types of chlorobutyl, bromobutyl and butyl base polymers. They were either fluoropolymer laminated (chlorobutyl 1, chlorobutyl 2, bromobutyl, butyl) or non-laminated (chlorobutyl 1). The study should help manufacturers choose a suitable stopper for moisture-sensitive lyophilized drug products.
The data revealed that a 1-hour drying cycle was not enough to remove the moisture driven into the stopper during the autoclave cycle. It was necessary to dry each stopper for at least 4 hours to return the moisture content in the stopper to the amount of moisture prior to steam sterilization. The residual moisture within the stoppers increased over time and leveled off around 18 or 24 months. The moisture content of the lactose increased over time as well and there was a slight increase in the moisture percentage of the lactose from 24 to 36 months. Best results were gained with an 8-hour drying time.
Read the full scientific poster here.
End-of-line rejections or sterility failures can affect drug availability and patient safety. As drugs evolve, demands on packaging systems increase. To meet the increasing quality needs of customers, West has introduced a line of superior quality elastomeric stoppers: Daikyo D Sigma components.<br />
Ensuring the safe containment of sensitive drug formulations requires a thorough evaluation of the container closure system. Selecting the packaging components requires knowledge about not only the drug formulation's requirements, but also the components’ material properties. Chemical compatibility of components with the drug formulation is key. Proper selection of components will provide the right closure design, assist with handling and help ensure container closure integrity throughout a drug product’s shelf life. Managing these factors well is critical, and West can help.
It’s official – the West Exton Headquarters building has been awarded Leadership in Energy and Environmental Design (LEED) Gold Certification from the US Green Building Council. LEED is an internationally recognized accreditation program that rewards best-in-class strategies and practices for the design, construction, operations and maintenance of environmentally friendly buildings. The Gold certification demonstrates to customers and the community that West is committed to its goals of sustainability.
Vial-based primary packaging systems for sterile drug products must provide protection over shelf life. This requires demonstration of container closure integrity (CCI); this testing should be performed early in the drug product development stage. As we all know, there is not one CCI test method that fits all systems/conditions.
Recently, there has been discussion in the industry regarding the utility of polymer-based vial containment systems for the storage and transport of gene therapy drug products, which can be performed as low as -80<sup>o</sup>C. Since it is known that all polymers are gas permeable, discussion has centered on whether polymer-based systems can sufficiently restrict ingress of oxygen (during refrigerated storage) and carbon dioxide (during transport on dry ice).
English
Chinese
